Corcept Therapeutics INC (CORT) SEC Filings — 2024

Filings

• Corcept Therapeutics Files 8-K — 8-K · Dec 30, 2024
• Corcept Therapeutics Files Q3 2024 10-Q — 10-Q · Oct 30, 2024
• Corcept Therapeutics Files Q2 2024 10-Q — 10-Q · Jul 29, 2024
• Corcept Therapeutics Announces New CMO Employment Agreement — 8-K · May 23, 2024
• Corcept Therapeutics Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 1, 2024
• Corcept Therapeutics Files Proxy Statement Supplement — DEFA14A · Apr 18, 2024
• Corcept Therapeutics Enters Material Definitive Agreement — 8-K · Apr 17, 2024
• Corcept Therapeutics Inc. Files Definitive Proxy Statement — DEF 14A · Apr 10, 2024
• Corcept Therapeutics INC SC 13G/A Filing — SC 13G/A · Mar 27, 2024
• Corcept Therapeutics Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024
• Corcept Therapeutics INC SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Corcept Therapeutics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Corcept Therapeutics INC SC 13G/A Filing — SC 13G/A · Feb 13, 2024
• Belanoff Maintains 6.58M Share Stake in Corcept Therapeutics — SC 13G/A · Feb 12, 2024
• BlackRock Amends Corcept Therapeutics Stake, Signals Continued Confidence — SC 13G/A · Jan 22, 2024
• Corcept Therapeutics Files 8-K on Operations & Financial Condition — 8-K · Jan 8, 2024
• Corcept Therapeutics Files Routine 8-K on Jan 2, 2024 — 8-K · Jan 2, 2024